1. All Products
  2. GLIBENCLAMIDE, 5mg, breakable tab.
Public Pricelist

GLIBENCLAMIDE, 5mg, breakable tab.

https://medicalguidelines.msf.org/en/node/411
https://unicat.msf.org/cat/product/12060
NST DORAGLIB5TB

Valid Article

Former Code(s): DORAGLIB5T-
18.5.2 - Oral hypoglycaemic agents
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
A10BB01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

GLIBENCLAMIDE - NST

Please always consider the MSF STD (Gliclazide) before ordering a NST.

Therapeutic Action

Sulphonylurea (stimulates insulin secretion)

Indications

Second-line treatment of type-2 diabetes in patients under 60 years

Prefer gliclazide for the same indication, given its lower risk of hypoglycaemia.

Instructions for use

Glibenclamide is used:

  • as monotherapy, when metformin is not tolerated or contraindicated.
  • in combination with metformin, when glycaemic control is inadequate with metformin alone.

Precautions for Use

Contraindicated in case of ketosis, porphyria.

Contraindicated during breastfeeding.

Caution must be taken in patients with renal or hepatic impairment, elderly, Ramadan or other fasting periods; stop during surgery, 1st trimester of pregnancy and trauma.

Stop administration during surgery, the 1st trimester of pregnancy or trauma.

Storage

Below 25°C ‐ Protect from sunlight